Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Efficacy of CagriSema on body composition in participants with early type 2 diabetes: REIMAGINE 1 

Authors :

Richard E. Pratley1; Rajdeep Adhya2; Anna Casu1; W. Timothy Garvey3; Joran Hjelmesæth4; Lars Johansson5; Alex Videmark6; Torquil Watt6; Vanita R. Aroda7

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Keywords
Diabetes
Congress oral presentation
Amylin
CagriSema
PHASE 3 (RCT)